News Cronos continues cash burn with US$161M loss in Q1 With revenue of just US$12.6M in Q1, the Canadian pot firm says it's finally ready to commercialize its synthetic cannabinoids joint venture Jared GnamMay 7, 2021
Industry update Cronos stock pops despite rising losses While third quarter revenues climbed 15% sequentially, the Ontario producer continues to pile up operating losses Jared GnamNovember 5, 2020
CBD Cronos stock craters on weak Canadian weed sales and US$107M loss Cronos says its massive cash pile will help it execute its global cannabis strategy as Covid-19 pandemic derails its US CBD strategy Jared GnamAugust 7, 2020
Canada Cronos continues to underwhelm in Q1, warns COVID-19 will hamper sales CEO Mike Gorenstein forecasts a 'bumpy' road ahead for Canada's weed industry Jared GnamMay 8, 2020
CBD CBD beauty market worth nearly US$1 billion by 2024: report Experts say regulations will smooth out the many uncertainties currently holding it back Jared GnamJanuary 25, 2020